OSSIO
Formerly Resorbium
Intelligent Bone Implant Technology
Startup D Health Tech & Life Sciences Est. 2014
Total Raised
$90.06M
D
Last Round
$27.6M
4 rounds
Investors
7
7 public
Team
3
51-200 employees
Confidence
100/100
News
10
articles
Patents
1
About
OSSIO is an orthopedic company providing an innovative alternative to metal implants in the more than $10 billion orthopedic fixation market with its intelligent bone implant technology. OSSIOfiber is a biofriendly implant material that is stronger than cortical bone and leaves nothing permanent behind. Stemming from years of biomechanical research and a vision for the possibility of better bone healing, OSSIOfiber is engineered to provide the strength required for functional fixation and allows for full integration into the native anatomy without adverse inflammation. OSSIOs proprietary technology can address many surgical applications through the manufacture of endless implant designs. In addition, OSSIOfiber implants utilize existing reimbursement and surgical techniques.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
orthopedicssurgeonsbiomaterialspatent-pendingdoctorshealthcare-providershospitalsrehabilitationregenerative-medicinemedical-productsclinicssurgerymedical-technologies
Funding & Events
Oct 2022
C Round $38.5M
MVM Life Science Partners, OurCrowd
May 2016
Seed $1.96M
Secocha Ventures (Lead)
Mar 2019
A Round $22M
OCV Partners, Secocha Ventures, Ortho Vision LLC
Dec 2024
D Round $27.6M
Questa Capital (Lead), MVM Life Science Partners, Courage Capital, OCV Partners
News (10)
Dec 2, 2024 · www.businesswire.com
OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues
Oct 18, 2022 · www.finsmes.com
growth-positive
Ossio Closes $38.5M Series C Financing
Investment
Aug 8, 2022 · www.businesswire.com
OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology
Mar 29, 2022 · www.businesswire.com
Growth-Positive
OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3
CustomersExpand
Mar 3, 2022 · www.odtmag.com
growth-positive
OSSIO Wins GPO Contract for Bio-Integrative Fixation Tech
Customers
growth-positive
Ossio gets FDA clearance for OSSIOfiber Hammertoe Fixation System
CustomersInvestment
Jun 11, 2019 · www.businesswire.com
OSSIO Receives Prestigious Frost & Sullivan New Product Innovation Award for its Breakthrough OSSIOfiberTM Intelligent Bone Regeneration Technology
May 16, 2019 · www.businesswire.com
OSSIO Announces U.S. Launch and First Commercial Use of the New OSSIOfiberTM Bone Pin for Hammertoe Correction
Mar 11, 2019 · www.businesswire.com
OSSIO Secures $22 Million in Financing
Jun 27, 2018 · www.beckersspine.com
growth-positive
Ossio prepares for US market entrance with new headquarters - 4 details
Expand
Details
Product Stage
Released
Employees
51-200
Exact Count
139
District
Center District
Founded
2014
Registrar
515104503
Crunchbase
ossio
Locations
HaTohen Street 8, Caesarea, Israel
300 Tradecenter Drive, Woburn, MA, USA
Links
Website
LinkedIn
Twitter
Facebook
Admin
Last Update
Feb 3, 2025
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
markets
Team (3)
Brian Verrier
CEO
Orahn Preiss-Bloom
Founder & CIO
Founder
Adina Friedman
Executive Assistant and HR coordinator
Internal
Created by
Rachel Wain (rachelwain18@gmail.com)
Created
2015-01-11T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)